| Product Name | MF | CAS | Details |
|---|
| N-Benzyl-3-nitropyridin-2-amine | C12H11N3O2 | 3723-70-4 | Details |
| 1,4-Dichloro-2-fluoro-5-nitrobenzene | C6H2Cl2FNO2 | 2624-66-0 | Details |
| 2-Chloro-N-(3-methoxypropyl)propanamide | C7H14ClNO2 | 1094292-31-5 | Details |
| 2-(2-Chloro-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C14H20BClO2 | 1549858-71-0 | Details |
| 1-Chloro-4-fluoro-5-nitroisoquinoline | C9H4ClFN2O2 | 928665-22-9 | Details |
| CTDNEP1 antibody (HRP) | Details |
| H-TNLESILSYPK-OH | Details |
| Succinimidyl-PEG(4)-[PEG(4)-OMe]3 | C60H110N6O28 | 1333154-70-3 | Details |
| KHDRBS2 antibody | Details |
| Clostridium botulinum A Toxoid antibody | Details |
| 4-Chloro-6-iodo-7-phenylsulfonyl-7H-pyrrolo[2,3-d]pyrimidine | C12H7ClIN3O2S | 876343-09-8 | Details |
| Penicilloic V acid | C16H20N2O6S | 1049-84-9 | Details |
| Proteomass insulin chain B oxidized MALDI-ms standard | C157H232N40O47S2 | 30003-72-6 | Details |
| 2-Bromobenzofuran | C8H5BrO | 54008-77-4 | Details |
| 2-Hydroxybicyclo[2.2.1]heptane-2-carboxylic acid | C8H12O3 | 41248-20-8 | Details |
| cis-1,2,6-Trimethylpiperazine | C7H16N2 | 147539-61-5 | Details |
| Amyloid beta-Protein (Human, 1-40) (Scrambled) | Details |
| Iomazenil | C15H14IN3O3 | 127985-21-1 | Details |
| 3-(4-Bromophenyl)-2,2-dimethylpropanoic acid | C11H13BrO2 | 186498-30-6 | Details |
| Nadifloxacin | C19H21FN2O4 | 124858-35-1 | Details |
| 1-Bromo-4-(prop-1-en-1-yl)benzene | C9H9Br | 4489-23-0 | Details |
| 2-Chlorothioxanthone | C13H7ClOS | 86-39-5 | Details |
| 1-[4-(Propan-2-yl)cyclohexyl]piperazine | C13H26N2 | 1344258-85-0 | Details |
| Hantavirus (Seoul) antibody | Details |
| Reserpinic acid hydrochloride | C22H28N2O5, HCl | 1910-70-9 | Details |
| C.I.Solubilised Vat Red 1 | C18H13Cl2NaO8S4 | 3875-72-7 | Details |
| 2-Chloro-N-[2-(quinolin-8-yl)ethyl]acetamide hydrochloride | C13H14Cl2N2O | 1394042-13-7 | Details |
| Ppp3cb Blocking Peptide | Details |
| Refametinib | C19H20F3IN2O5S | 923032-37-5 | Details |
| 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-8-methoxy-4H-chromen-4-one | C16H12O7 | 571-74-4 | Details |
| Rr-11a analog | C22H29N5O8 | 685543-66-2 | Details |
| IL19 antibody | Details |
| 4-Chloro-N-(2-ethoxyethyl)aniline hydrochloride | C10H15Cl2NO | 1909308-70-8 | Details |
| (αR)-N-[2-[2-[(6-Chlorohexyl)oxy]ethoxy]ethyl]-α-methyltricyclo[3.3.1.13,7]decane-1-butanamide | C25H44ClNO3 | 1323151-45-6 | Details |
| Toxoplasma Gondii Negative Human Plasma | Details |
| 18-Norabieta-8,11,13-triene-4,15-diol | C19H28O2 | 203455-81-6 | Details |
| (5-Methoxy-pyridin-3-yl)-methyl-amine | C7H10N2O | 1104455-50-6 | Details |
| 2’,3’,5’-Tri-O-benzoyl-2’C-methyl-3-deazauridine | C32H27NO9 | 2072145-54-9 | Details |
| N-(4-Fluoro-3-methylphenyl)oxan-4-amine | C12H16FNO | 1342996-02-4 | Details |
| ZNHIT1 antibody | Details |
| 2-(4-Ethylphenoxy)-1-(piperazin-1-yl)propan-1-one hydrochloride | C15H22N2O2.HCl | 1334147-49-7 | Details |
| N-(4-Hydroxyphenethyl)pent-4-ynamide | C13H15NO2 | 1694495-59-4 | Details |
| 2-Methylbenzhydrol | C14H14O | 5472-13-9 | Details |
| H-NSILTETLHR-OH | Details |
| 4-O-Acetyl-3,6-di-O-(3,4,6-tri-O-acetyl-1,2-ethylidene-b-D-mannopyranosyl)-1,2-ethylidene-b-D-mannopyranose | C38H52O25 | 230963-27-6 | Details |
| 3-Bromo-4-(chloromethyl)-5-fluoropyridine | C6H4BrClFN | 1227573-06-9 | Details |
| Phospho-glycogen synthase peptide-2(substrate) | C123H191N40O48P | 851366-97-7 | Details |
| N-Cyclopropyl-2-methyl-6-nitroaniline | C10H12N2O2 | 1353977-68-0 | Details |
| Allylhydrazine Dihydrochloride | C3H10Cl2N2 | 70629-62-8 | Details |
| Cis-2-Benzyltetrahydropyrrolo[3,4-C]Pyrrole-1,3(2H,3Ah)-Dione | C13H14N2O2 | 189348-40-1 | Details |
| N-((5,5-dimethyl-3-oxocyclohex-1-enyl)amino)-2-((4-methylphenyl)sulfonyl)ethanamide | C17H22N2O4S | 1022406-91-2 | Details |
| 2-Bromo-6-(4-chlorophenyl)imidazo[2,1-b][1,3,4]thiadiazole | C10H5BrClN3S | 1094279-94-3 | Details |
| 2-(4-Iodo-3-methyl-1H-pyrazol-1-yl)butanoic acid | C8H11IN2O2 | 1354705-28-4 | Details |
| (3-Chlorophenyl)(3-methylphenyl)methanamine | C14H14ClN | 1184429-99-9 | Details |
| CD44 antibody (PE) | Details |
| 6-(((tert-Butoxycarbonyl)amino)methyl)imidazo[1,2-a]pyridine-2-carboxylic acid | C14H17N3O4 | 1038916-43-6 | Details |
| Reactive Yellow 3 - Technical | C21H17ClN8O7S2 | 6539-67-9 | Details |
| 1-(3-Fluorophenyl)-2-Thiourea | C7H7FN2S | 458-05-9 | Details |
| Flumetsulam | C12H9F2N5O2S | 98967-40-9 | Details |
| 2-(1-Naphthyloxy)acetohydrazide | C12H12N2O2 | 24310-15-4 | Details |
| aR-C 118925Xx | C28H23N7O3S | 216657-60-2 | Details |
| 3-(Ethylamino)phenol Hemisulfate | C16H24N2O6S | 1274892-48-6 | Details |
| 4-(Methylamino)butan-2-one hydrochloride | C5H12ClNO | 26387-62-2 | Details |
| 1,2,3,4-Tetrahydroquinoline-1-sulfonamide | C9H12N2O2S | 1152573-61-9 | Details |
| 2-(2-Aminoethyl)-5-methyl-1,4,5,6-tetrahydropyrimidine-4,6-dione dihydrochloride | C7H12ClN3O2 | 1423027-89-7 | Details |
| 3-(4,5-Dimethyl-2-oxo-2,3-dihydro-1,3-thiazol-3-yl)propanoic acid | C8H11NO3S | 926214-43-9 | Details |
| CDKL3 antibody | Details |
| OR13C5 antibody | Details |
| Ethyl 4-formyl-1-(oxan-4-yl)-1H-pyrazole-3-carboxylate | C12H16N2O4 | 2138085-66-0 | Details |
| 2,6-Dichloro-N-methylaniline | C7H7Cl2N | 56462-00-1 | Details |
| tert-Butyl 3-(2-fluorophenyl)-3-hydroxyazetidine-1-carboxylate | C14H18FNO3 | 1225439-46-2 | Details |
| 4-Nitrophenyl-alpha-D-maltohexaoside | C42H65NO33 | 74173-30-1 | Details |
| 5-(Chloromethyl)-2-(2,4-dimethoxyphenyl)-1,3-oxazolidine | C12H16ClNO3 | 565201-77-6 | Details |
| (4-(2,5-dimethylphenyl)piperazinyl)-N-(4-methylphenyl)formamide | C20H25N3O | 925603-42-5 | Details |
| Methost-8-enol | C28H48O | 5241-22-5 | Details |
| (2R,3S,4R)-3,4-Dihydroxypyrrolidine-2-carboxylic acid | C5H9NO4 | 17663-43-3 | Details |
| Aldol??470 butyrate, Biosynth Patent: EP 2427431 and US 8940909 | C27H25NO5 | 2484872-49-1 | Details |
| 5-Bromo-N-(4-methyl-4H-1,2,4-triazol-3-yl)pyridine-2-carboxamide | C9H8BrN5O | 1856778-43-2 | Details |
| Integrin Beta 8 antibody | Details |
| 5-Methyl-1-(4-methylphenyl)-1H-pyrazole-3-carboxylic acid | C12H12N2O2 | 835-60-9 | Details |
| H-TLLSNLEEAK-OH | Details |
| 2-[(4-Methylcyclohexyl)sulfamoyl]acetic acid | C9H17NO4S | 1042586-01-5 | Details |
| 3-(3-Methylbutoxy)aniline | C11H17NO | 17258-52-5 | Details |
| N-(3-Cyanophenyl)-2-fluorobenzamide | C14H9FN2O | 709647-30-3 | Details |
| APF Sialoglycopeptide ammonium | C63H107N11O29 | 845730-65-6 | Details |
| STATH antibody | Details |
| Ethyl 3-(4-fluorobenzenesulfonyl)propanoate | C11H13FO4S | 1099681-75-0 | Details |
| 7,8-Dimethyl-1,2,3,4-tetrahydroquinoline | C11H15N | 57414-64-9 | Details |
| 1-(Oxolan-3-yl)-1H-1,2,3-triazol-4-amine hydrochloride | 2230800-26-5 | Details |
| 3-(5-Iodo-4-hydroxy-3-methoxy)cinnamic acid | C10H9IO4 | 61223-30-1 | Details |
| Benzyl b-D-arabinopyranoside | C12H16O5 | 5329-50-0 | Details |
| 4-(Tetrahydro-2H-pyran-4-yl)benzoic acid | C12H14O3 | 1086391-97-0 | Details |
| KLSDW (EYGF-33) | Details |
| 3-Azatricyclo[7.3.1.0,5,13]trideca-5,7,9(13)-triene hydrochloride | 42025-42-3 | Details |
| 5-Ethynyl-1-(propan-2-yl)-1H-pyrazole | C8H10N2 | 1690560-11-2 | Details |
| 3-Cyclopentyloxy-benzaldehyde | C12H14O2 | 273722-75-1 | Details |
| 3,4-Dichloro-2-methylpyridine | C6H5Cl2N | 103949-58-2 | Details |
| (1-Ethyl-1H-1,2,3-triazol-4-yl)methanamine hydrochloride | C5H11ClN4 | 1955548-17-0 | Details |
| 1-Deoxyfructosyl-Val-His-[D7]Leu-Thr-Pro-Glu | Details |
| H-Gln-2-ClTrt-Resin (100-200 mesh) 1% DVB | Details |
| Product Total： Product Page： | ||||
| 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 | ||||